Jubilant Cadista Pharmaceuticals
Kayla Bowden is a seasoned professional in the pharmaceutical compliance field, currently serving as a Senior Compliance Specialist at Cadista Pharmaceuticals since June 2017. In this role, Kayla manages the Stability Program, writes and reviews Annual Product Reviews (APRs), conducts deviation investigations, and oversees quality control test method revisions along with associated SAP updates. Kayla is also responsible for reviewing and approving Standard Operating Procedure (SOP) revisions, change controls, deviations, and Corrective and Preventive Actions (CAPAs), as well as vendor and material qualification. Additionally, Kayla has played a key role in the implementation of MasterControl and is recognized as a subject matter expert in TrackWise, MasterControl, and ComplianceWire. Previously, Kayla held various compliance and administrative positions with Accohannock Indian Tribe Inc. from June 2010 to 2015. Kayla earned a Bachelor of Science degree in Biology from the University of Maryland Eastern Shore between 2012 and 2016.
Jubilant Cadista Pharmaceuticals
Headquartered in Salisbury, Maryland, Jubilant Cadista Pharmaceuticals Inc. is a noted, Top 10 fastest growing generic pharmaceutical company in the United States. Vertically integrated with the parent company (Jubilant Life Sciences) in India, Cadista applies its local market expertise and technical capabilities to all forms of solid dose products to enhance patient outcomes. Cadista employs approximately 300 employees and generates approximately 120MM in annual revenue. The site is uniquely located on the Eastern Shore within 30 minutes east of beautiful Ocean City, Maryland and the same to the Chesapeake Bay to the west. For more information, visit www.cadista.com.